Idiopathic pulmonary fibrosis: evolving concepts.

[1]  G. Raghu,et al.  Treatment of Idiopathic Pulmonary Fibrosis. , 2016, Annals of the American Thoracic Society.

[2]  R. Borie,et al.  Familial pulmonary fibrosis. , 2015, Revue des maladies respiratoires.

[3]  J. Connett,et al.  Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis. , 2014, The American journal of pathology.

[4]  V. Poletti,et al.  Transbronchial Lung Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Diseases , 2014, PloS one.

[5]  H. Collard,et al.  Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. , 2014, American journal of respiratory and critical care medicine.

[6]  O. Hilberg,et al.  Idiopathic Pulmonary Fibrosis - Diagnosis and Treatment , 2014 .

[7]  P. Sime,et al.  New light is shed on the enigmatic origin of the lung myofibroblast. , 2013, American journal of respiratory and critical care medicine.

[8]  A. Wells,et al.  Acute Exacerbations of Idiopathic Pulmonary Fibrosis , 2013, Respiration.

[9]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[10]  V. Poletti,et al.  Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. , 2013, Translational research : the journal of laboratory and clinical medicine.

[11]  C. Shimbori,et al.  Extracellular matrix microenvironment contributes actively to pulmonary fibrosis , 2013, Current opinion in pulmonary medicine.

[12]  T. Maher.  Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine , 2013, Current opinion in pulmonary medicine.

[13]  M. Selman,et al.  Telomerase and telomere length in pulmonary fibrosis. , 2013, American journal of respiratory cell and molecular biology.

[14]  Joyce S Lee,et al.  Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. , 2013, The Lancet. Respiratory medicine.

[15]  Joyce S Lee,et al.  Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. , 2013, Chest.

[16]  S. Gläser,et al.  Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis – The Predictive Value of Exercise Capacity and Gas Exchange Efficiency , 2013, PloS one.

[17]  A. Karakatsani,et al.  Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis. , 2013, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[18]  I. Noth,et al.  Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. , 2013, JAMA.

[19]  J. Parish,et al.  Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies. Clinical, radiological and histopathological clues to aetiology , 2013, Journal of Clinical Pathology.

[20]  G. Raghu,et al.  Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial , 2013, European Respiratory Journal.

[21]  Artemis-Ipf Investigators.  Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial , 2013 .

[22]  E. Savarino,et al.  Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients , 2013, European Respiratory Journal.

[23]  S. Phan.  Genesis of the myofibroblast in lung injury and fibrosis. , 2012, Proceedings of the American Thoracic Society.

[24]  R. Chambers,et al.  Coagulation cascade proteinases in lung injury and fibrosis. , 2012, Proceedings of the American Thoracic Society.

[25]  Y. Kaji,et al.  Lung cancer in chronic interstitial pneumonia: early manifestation from serial CT observations. , 2012, AJR. American journal of roentgenology.

[26]  J. Behr,et al.  Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease , 2012, European Respiratory Journal.

[27]  K. Horton,et al.  Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.

[28]  S. Sharma.  Diagnosing idiopathic pulmonary fibrosis: to biopsy or not to biopsy. , 2012, Current opinion in pulmonary medicine.

[29]  N. Kaminski,et al.  Biomarkers in idiopathic pulmonary fibrosis , 2012, Current opinion in pulmonary medicine.

[30]  R. Borie,et al.  Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background , 2012, Current opinion in pulmonary medicine.

[31]  C. Barkauskas,et al.  Pulmonary fibrosis: patterns and perpetrators. , 2012, The Journal of clinical investigation.

[32]  K. Anstrom,et al.  A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.

[33]  K. Leslie.  Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. , 2012, Archives of pathology & laboratory medicine.

[34]  Kevin J Anstrom,et al.  Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.

[35]  Joyce S Lee,et al.  A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.

[36]  H. Collard,et al.  Dyspnea in idiopathic pulmonary fibrosis: a systematic review. , 2012, Journal of pain and symptom management.

[37]  Imre Noth,et al.  Peripheral blood biomarkers in idiopathic pulmonary fibrosis. , 2012, Translational research : the journal of laboratory and clinical medicine.

[38]  C. Fell.  Idiopathic pulmonary fibrosis: phenotypes and comorbidities. , 2012, Clinics in chest medicine.

[39]  Mary Ellen Kitler,et al.  European Respiratory Society , 2005, International Journal of Pharmaceutical Medicine.

[40]  S. Rounds,et al.  Combined pulmonary fibrosis and emphysema syndrome: a review. , 2012, Chest.

[41]  C. Spradley.  Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis , 2012 .

[42]  J. Behr.  Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.

[43]  H. Collard,et al.  Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis , 2011, European Respiratory Journal.

[44]  Moisés Selman,et al.  Idiopathic pulmonary fibrosis , 2011, The Lancet.

[45]  Natalie J. Carter.  Pirfenidone , 2011, Drugs.

[46]  K. Brown,et al.  Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease , 2011, European Respiratory Journal.

[47]  L. Farkas,et al.  Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. , 2011, American journal of respiratory cell and molecular biology.

[48]  B. Make,et al.  Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis , 2011, Respiratory Care.

[49]  S. Sahn,et al.  Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials , 2011, The Lancet.

[50]  Ivana V. Yang,et al.  A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.

[51]  Y. Shim,et al.  Prediction of acute pulmonary complications after resection of lung cancer in patients with preexisting interstitial lung disease. , 2011, The Thoracic and cardiovascular surgeon.

[52]  H. Arakawa,et al.  Honeycomb lung: history and current concepts. , 2011, AJR. American journal of roentgenology.

[53]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[54]  H. Collard,et al.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[55]  G. Raghu,et al.  Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[56]  D. Lynch,et al.  BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[57]  H. Collard,et al.  A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.

[58]  B. Nordestgaard,et al.  Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study. , 2010, American journal of respiratory and critical care medicine.

[59]  D. Fairclough,et al.  Pirfenidone in idiopathic pulmonary fibrosis , 2010, European Respiratory Journal.

[60]  H. Collard,et al.  Does chronic microaspiration cause idiopathic pulmonary fibrosis? , 2010, The American journal of medicine.

[61]  D. Schroeder,et al.  Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. , 2010, American journal of respiratory and critical care medicine.

[62]  R. Bois,et al.  Strategies for treating idiopathic pulmonary fibrosis , 2010, Nature Reviews Drug Discovery.

[63]  D. Schroeder,et al.  Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. , 2010, Chest.

[64]  G. Raghu,et al.  Pirfenidone in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.

[65]  I. D. Johnston,et al.  Cryptogenic fibrosing alveolitis and lung cancer: the BTS study , 2009, Thorax.

[66]  H. Collard,et al.  Idiopathic interstitial pneumonias. , 2009, Journal of thoracic imaging.

[67]  F. Maldonado,et al.  Surgical biopsy for diffuse parenchymal lung diseases: are we causing more harm than good? , 2009, Journal of bronchology & interventional pulmonology.

[68]  H. Collard,et al.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. , 2009, Chest.

[69]  A. Prasse,et al.  Non‐invasive biomarkers in pulmonary fibrosis , 2009 .

[70]  M. Humbert,et al.  Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome , 2009, European Respiratory Journal.

[71]  S. Sahn,et al.  Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial , 2009, The Lancet.

[72]  T. Suarez,et al.  Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. , 2009, Chest.

[73]  N. Kohno,et al.  Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[74]  N. Grishin,et al.  Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. , 2009, American journal of human genetics.

[75]  M. Raza.  BUILD-1: A Randomized Placebo-Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis , 2009 .

[76]  G. Snell,et al.  Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years. , 2009, Transplantation proceedings.

[77]  R. Hubbard,et al.  The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. , 2008, American journal of respiratory and critical care medicine.

[78]  D. Coultas,et al.  Exposures and Idiopathic Lung Disease , 2008, Seminars in respiratory and critical care medicine.

[79]  G. Raghu,et al.  Telomere shortening in familial and sporadic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.

[80]  P. Lansdorp,et al.  Short telomeres are a risk factor for idiopathic pulmonary fibrosis , 2008, Proceedings of the National Academy of Sciences.

[81]  J. Myers,et al.  Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. , 2008, Chest.

[82]  J. Ryu,et al.  Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis , 2008, European Respiratory Journal.

[83]  J. Behr,et al.  Pulmonary hypertension in interstitial lung disease , 2008, European Respiratory Journal.

[84]  A. Holland,et al.  Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease , 2008, Thorax.

[85]  M. Takahama,et al.  Operative indications for lung cancer with idiopathic pulmonary fibrosis. , 2007, The Thoracic and cardiovascular surgeon.

[86]  R. Hubbard,et al.  The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. , 2007, Respiratory medicine.

[87]  T. Hartman,et al.  Diagnosis of interstitial lung diseases. , 2007, Mayo Clinic proceedings.

[88]  Sang-Do Lee,et al.  Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[89]  N. Kaminski,et al.  Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern , 2007, PloS one.

[90]  S. Nathan,et al.  Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. , 2007, American journal of respiratory and critical care medicine.

[91]  J. Golden,et al.  Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. , 2007, The Journal of thoracic and cardiovascular surgery.

[92]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[93]  J. Parish,et al.  Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. , 2007, Archives of pathology & laboratory medicine.

[94]  H. Collard,et al.  Sildenafil improves walk distance in idiopathic pulmonary fibrosis. , 2007, Chest.

[95]  H. Collard,et al.  Acute exacerbations of idiopathic pulmonary fibrosis. , 2007, American journal of respiratory and critical care medicine.

[96]  G. Oster,et al.  Incidence and prevalence of idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.

[97]  D. J. Riley,et al.  Surgical biopsy: its appropriateness in diagnosing interstitial lung disease , 2006, Current opinion in pulmonary medicine.

[98]  A. Limper,et al.  Idiopathic pulmonary fibrosis: is it a familial disease? , 2006, Current opinion in pulmonary medicine.

[99]  Kevin Flaherty,et al.  Pulmonary function testing in idiopathic interstitial pneumonias. , 2006, Proceedings of the American Thoracic Society.

[100]  D. Lynch,et al.  Idiopathic pulmonary fibrosis/usual interstitial pneumonia: imaging diagnosis, spectrum of abnormalities, and temporal progression. , 2006, Proceedings of the American Thoracic Society.

[101]  D. Sugarbaker,et al.  Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. , 2006, The Journal of thoracic and cardiovascular surgery.

[102]  G. Raghu,et al.  High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis , 2006, European Respiratory Journal.

[103]  A. Kurosaki,et al.  High-Resolution Computed Tomography Findings of Lung Cancer Associated With Idiopathic Pulmonary Fibrosis , 2006, Journal of computer assisted tomography.

[104]  K. Brown.  Chronic cough due to chronic interstitial pulmonary diseases: ACCP evidence-based clinical practice guidelines. , 2006, Chest.

[105]  N. Kaminski,et al.  Abnormal vascular phenotypes in patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension. , 2005, Chest.

[106]  Johny Verschakelen,et al.  High-dose acetylcysteine in idiopathic pulmonary fibrosis. , 2005, The New England journal of medicine.

[107]  H Page McAdams,et al.  Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[108]  J. Myers,et al.  Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. , 2005, Chest.

[109]  P. Brillet,et al.  Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity , 2005, European Respiratory Journal.

[110]  Katsutoshi Nakayama,et al.  Anticoagulant therapy for idiopathic pulmonary fibrosis. , 2005, Chest.

[111]  J. Jett,et al.  Does interstitial lung disease predispose to lung cancer? , 2005, Current opinion in pulmonary medicine.

[112]  David A Lynch,et al.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. , 2005, American journal of respiratory and critical care medicine.

[113]  Demosthenes Bouros,et al.  Serum biomarkers in interstitial lung diseases , 2005, Respiratory research.

[114]  T. Hartman,et al.  Familial idiopathic pulmonary fibrosis: clinical features and outcome. , 2005, Chest.

[115]  S. Kudoh,et al.  Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.

[116]  J. Myers,et al.  Idiopathic pulmonary fibrosis in patients younger than 50 years. , 2005, Mayo Clinic proceedings.

[117]  Susan Murray,et al.  Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? , 2004, American journal of respiratory and critical care medicine.

[118]  E. Cantu,et al.  Early Fundoplication Prevents Chronic Allograft Dysfunction in Patients with Gastroesophageal Reflux Disease , 2004 .

[119]  G. Raghu,et al.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.

[120]  R. Newton,et al.  A study of the cough reflex in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[121]  Y. Castier,et al.  Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. , 2003, The Journal of thoracic and cardiovascular surgery.

[122]  A. Nicholson,et al.  Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.

[123]  M. Steele,et al.  Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. , 2003, The Journal of thoracic and cardiovascular surgery.

[124]  H. Collard,et al.  Demystifying idiopathic interstitial pneumonia. , 2003, Archives of internal medicine.

[125]  B. Afessa,et al.  Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. , 2002, American journal of respiratory and critical care medicine.

[126]  V. Pankratz,et al.  Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. , 2002, Mayo Clinic proceedings.

[127]  Jonathan Haines,et al.  Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. , 2002, American journal of respiratory and critical care medicine.

[128]  M. Wahidi,et al.  Familial pulmonary fibrosis in the United States. , 2002, Chest.

[129]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[130]  J. Gauldie.  Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[131]  P. Jolliet,et al.  Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis , 2001, Intensive Care Medicine.

[132]  J. Tooze,et al.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.

[133]  H. Mal,et al.  Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. , 2001, Chest.

[134]  D. Schroeder,et al.  High short-term mortality following lung biopsy for usual interstitial pneumonia. , 2001, The European respiratory journal.

[135]  A. Pardo,et al.  Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.

[136]  M. Selman,et al.  AMERICAN THORACIC SOCIETY; EUROPEAN RESPIRATORY SOCIETY; AMERICAN COLLEGE OF CHEST PHYSICIANS. IDIOPATHIC PULMONARY FIBROSIS: PREVAILING AND EVOLVING HYPOTHESES ABOUT ITS PATHOGENESIS AND IMPLICATIONS FOR THERAPY , 2001 .

[137]  D. Schroeder,et al.  Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. , 2000, American journal of respiratory and critical care medicine.

[138]  R. Hubbard,et al.  Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. , 2000, American journal of respiratory and critical care medicine.

[139]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[140]  V. Petkov,et al.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.

[141]  A. Nicholson,et al.  A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. , 1999, American journal of respiratory and critical care medicine.

[142]  T. Colby,et al.  Erratum: Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP (European Respiratory Journal (1998) 12 (1010-1019)) , 1999 .

[143]  G. Raghu,et al.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[144]  T. Hartman,et al.  Idiopathic pulmonary fibrosis: current concepts. , 1998, Mayo Clinic proceedings.

[145]  T. Colby,et al.  Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. , 1998, The European respiratory journal.

[146]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[147]  K P Offord,et al.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[148]  S. Swensen,et al.  Colchicine versus prednisone as treatment of usual interstitial pneumonia. , 1997, Mayo Clinic proceedings.

[149]  G. Gurujeyalakshmi,et al.  Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. , 1995, Experimental lung research.

[150]  T. King,et al.  Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. , 1990, The American journal of medicine.

[151]  M. Schwarz.  Idiopathic pulmonary fibrosis. , 1988, The Western journal of medicine.

[152]  J. Macmillan.  Familial pulmonary fibrosis. , 1951, Diseases of the chest.

[153]  A. Rich,et al.  Fulminating Diffuse Interstitial Fibrosis of the Lungs. , 1935, Transactions of the American Clinical and Climatological Association.